| CYHS2400719 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs(4) | Generic Drug | 2024-02-29 | | Guangzhou Keruite Pharmaceutical Co Ltd | | | view |
| CYHS2200622 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs(4) | Generic Drug | 2022-04-21 | | Shandong Langnuo Pharmaceutical Co Ltd | | | view |
| JYHZ2200058 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | License Renew | 2022-03-04 | | | | | view |
| JYHZ2200055 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | License Renew | 2022-03-04 | | | | | view |
| JYHZ2200056 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | License Renew | 2022-03-04 | | | | | view |
| JYHZ2200057 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | License Renew | 2022-03-04 | | | | | view |
| JYHB2200037 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | Supplementary Application | 2022-01-18 | | | | | view |
| JYHB2200038 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | Supplementary Application | 2022-01-18 | | | | | view |
| JYHB2200036 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | Supplementary Application | 2022-01-18 | | | | | view |
| JYHB2200035 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | Supplementary Application | 2022-01-18 | | | | | view |
| JYHS2200003 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs(5.2) | Import Drug Application | 2022-01-17 | | | | | view |
| CYHS2102310 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs(4) | Generic Drug | 2021-12-29 | | Jilin Aodong--Taonan Pharnalentical Company Ltd | | | view |
| JTH2100655 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | Disposable Import Drug Application | 2021-09-18 | | | | | view |
| JYHB2100037 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | Supplementary Application | 2021-01-19 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2021-01-18 | view |
| JYHB2100036 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | Supplementary Application | 2021-01-19 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2021-01-18 | view |
| JYHB2100038 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | Supplementary Application | 2021-01-19 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2021-01-18 | view |
| JYHB2100039 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | Supplementary Application | 2021-01-08 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2021-01-07 | view |
| JYHB2002713 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | Supplementary Application | 2020-12-30 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Filed | 2021-01-15 | view |
| JYHB2001040 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | Supplementary Application | 2020-07-04 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2020-08-27 | view |
| JYHB2001039 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | Supplementary Application | 2020-07-04 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2020-08-27 | view |
